A2 Milk (ASX:A2M) share price on watch following investor update

A2 Milk has laid out its growth plans…

| More on:
a cute young girl with curly hair sips a glass of milk through a straw with a smile on her face.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The A2 Milk Company Ltd (ASX: A2M) share price will be one to watch on Wednesday.

This follows the release of the infant formula (IMF) company's 162-page investor update this morning.

Below is a summary of some of the key highlights from the presentation.

Revised growth strategy

One of the key highlights from the presentation is the company's decision to revise its growth strategy.

Management has stated that its new strategy is focused on rebuilding the company into an exciting, innovative and sustainable growth company, and has named five strategic priorities that it believes will help it achieve its ambitions.

The first one is investing in people and planet leadership. The company intends to invest in its people to help them thrive. It also wants to get on the green bandwagon by taking direct action to lead the industry in GHG emissions reduction and farming practices. A2 Milk is aiming to reduce its scope one and two greenhouse gas emissions to net zero by 2030 and scope three emissions to net zero by 2040.

Another strategic priority is capturing the full potential of the China IMF market. This will see the company aim to gain more control over its Chinese label (CL) and English label (EL) distribution and get closer to the consumer. It also intends to increase its investment in the A2 Brand, digital markets, and ecommerce.

A2 Milk intends to ramp-up product innovation. This will see the company expand its CL and EL IMF product portfolios and enter adjacent product categories to drive growth.

Another focus will be the transformation of its supply chain. It intends to expand CL registered market access, utilise its Mataura Valley Milk (MVM) capability, and develop a China supply capability.

A final priority will be accelerating its path to profitability. Management notes that it will take action to realise potential in the US and expedite insourcing and third party volume to significantly increase MVM utilisation.

NZ$2 billion sales target

The sum of the above, is the company setting itself a medium term (≥ 5 years) target of growing its sales to NZ$2 billion. This compares favourably to FY 2021's sales of NZ$1.2 billion but only modestly to FY 2020's pre-COVID sales of NZ$1.73 billion.

In respect to margins, A2 Milk will be targeting EBITDA margins "probably" in the teens in the medium term due to expected market conditions, investment, and innovation. This compares to its pre-COVID EBITDA margin of 31.7%.

These targets appear broadly in line with what analysts at Bell Potter were forecasting. The broker recently pencilled in an EBITDA margin of ~17.5% on revenue of NZ$1,472 million in FY 2023 and revenue of NZ$1,584 in FY 2024.

Management commentary

A2 Milk Company's Managing Director and CEO, David Bortolussi, commented: "The China infant milk formula market has experienced unprecedented change over the past 12 months which has required us to adapt our growth strategy. Our ambition is to rebuild The a2 Milk Company into an exciting, innovative and sustainable growth company."

"We will innovate and expand our infant milk formula product portfolio to appeal to a broader set of consumers and to maximise our distribution potential. Outside our core business, we are considering opportunities for adjacent category growth in China, ANZ and the USA as well as assessing opportunities in new emerging markets."

The A2 Milk share price is down 6% in early trade on the New Zealand stock exchange.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended A2 Milk. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A man looks surprised as a woman whispers in his ear.
Broker Notes

These ASX 200 shares could rise 20% to 40%

Analysts are tipping these shares to deliver market-beating returns over the next 12 months.

Read more »

a young woman looks happily at her phone in one hand with a selection of shopping bags in her other hand.
Share Market News

This leading fundie just bought more Zip shares. Here's why

Are Zip shares worth a closer look following institutional backing?

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a spectacular end to the trading week for the ASX today.

Read more »

A piggy bank on the cloud in the blue sky symbolising a record high share price.
52-Week Highs

These 13 ASX 200 shares just hit new 52-week highs

These shares had a fine send-off to the weekend this Friday.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
Share Fallers

Why AMP, Civmec, Cochlear, and LGI shares are falling today

These shares are ending the week in the red. But why?

Read more »

Three people jumping cheerfully in clear sunny weather.
Share Gainers

These 3 ASX 200 stocks are shooting the lights out this week. Own any?

These ASX 200 shares have soared 11% to almost 23% this week. But why?

Read more »

Two smiling work colleagues discuss an investment or business plan at their office.
Share Gainers

Why GQG, Imugene, Mirvac, and Temple & Webster shares are pushing higher

These shares are ending the week on a positive note. But why?

Read more »